Trop2 regulates the proliferation and differentiation of murine compact-bone derived MSCs

Jianye Yang1, Zhaohui Zhu, Hongfei Wang

  • 1Department of Cardio-Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.

Insights

Trop2 protein regulates mesenchymal stem cell (MSC) fate. Trop2 deficiency in mice inhibited MSC proliferation and differentiation, impacting AKT activation and cell cycle progression.

Area of Science:

  • Stem Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mesenchymal stem cells (MSCs) hold therapeutic promise for tissue repair and engineering.
  • Understanding MSC fate regulation is crucial for optimizing cell-based therapies.
  • Trop2, a protein often overexpressed in cancer, was investigated for its role in MSCs.

Purpose of the Study:

  • To investigate the functional role of Trop2 in mesenchymal stem cells.
  • To elucidate the relationship between Trop2 expression and MSC proliferation and differentiation.
  • To generate a Trop2 knockout mouse model for in vivo studies.

Main Methods:

  • Construction of a Trop2 gene knockout mouse model using homologous recombination.
  • Analysis of MSC proliferation rates, cell cycle progression (S phase entry), and doubling times.
  • Assessment of adipogenesis and osteogenesis in Trop2-deficient MSCs.
  • Evaluation of AKT activation and cyclin D1 expression levels.

Main Results:

  • Trop2 is exclusively expressed on the MSC membrane.
  • Trop2 deficiency significantly inhibited MSC proliferation and delayed cell cycle progression.
  • Impaired adipogenesis and osteogenesis were observed in Trop2-deficient MSCs.
  • AKT activation was reduced, and cyclin D1 expression was downregulated in Trop2-deficient MSCs.

Conclusions:

  • Trop2 plays a critical role in regulating MSC proliferation, differentiation, and self-renewal.
  • Findings establish a functional link between Trop2 and MSC biology.
  • The Trop2 knockout mouse model serves as a valuable tool for future stem cell research.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...